It converts the amino acid serine into another amino acid called glycine by transferring a carbon atom to tetrahydrofolate, a reduced form of folic acid. This reaction produces building blocks for ...
In just two neutron experiments, scientists discovered remarkable details about the function of an enzyme that can aid drug design for aggressive cancers.
GlobalData’s report assesses the drugs in the Dihydrofolate Reductase pipeline by therapy areas, indications, stages, MoA, RoA, molecule type and the key players in the development pipeline.